Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302)
Status:
Completed
Trial end date:
2012-06-01
Target enrollment:
Participant gender:
Summary
The study is a randomized Phase II, four arm treatment trial. The primary purpose of the
study is to define new agents with promising activity against acute graft-versus-host disease
(GVHD) suitable for testing against corticosteroids alone in a subsequent Phase III trial.
Phase:
Phase 2
Details
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Collaborators:
Blood and Marrow Transplant Clinical Trials Network National Cancer Institute (NCI)